Nasdaq: TRXB · Listed Oct 9, 2026
Trex Bio IPO
$9.57
▼ -4.30%today · -31.64% since the $14.00 IPO price
15-minute delayed · as of 5:51:47 AM EST on Nov 19, 2026
Trex Bio (TRXB) priced its IPO at $14.00 a share and has traded on Nasdaq since Oct 9, 2026.
Last session · Nov 18, 2026
- Market cap
- $257.71M
- from the ticker reference
- Volume
- 246.56K
- shares, regular session
- VWAP
- $10.00
- the last price is -4.27% from the volume-weighted average
- Day range
- 9.06–11.24
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
TRXB against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
TRXB against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Trex Bio '26 | $116.67M | -3.57% | +10.57% | +2.39% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Trex Bio IPO offers 8.33M shares to raise $116.67M, before any underwriters' option.
- Expected price range
- $14 to $16
- IPO price
- $14.00
- Shares offered
- 8.33M
- Money raised
- $116.67M
- Listing date
- Oct 9, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Trex Bio$116.67M
Where TRXB ranks
Trex Bio's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- TRXB$257.71M
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 9, 2026
First trade
Prices, bars, and snapshots
Oct 14, 2026 · est.
Options list
Option chain and open interest
Oct 29, 2026 · est.
First short interest
Short interest and daily short volume
Nov 3, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 6, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What Trex Bio has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Trex Bio discloses to the SEC on Form 8-K.
- Quarterly earningsNov 13, 2026
On November 13, 2026, TRex Bio, Inc. (the "Company") issued a press release announcing the Company's financial results for the quarter ended September 30, 2026.
- Bylaw amendmentOct 13, 2026
On October 13, 2026, in connection with the consummation of the IPO, the second amended and restated bylaws of the Company ... became effective. The Amended and Restated Bylaws ... (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings, (ii) establish procedures relating to the nomination of directors, (iii) modify the indemnification provisions for the Company's directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.
About Trex Bio
Trex Bio Inc is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.
- Ticker
- TRXB
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Listed
- Oct 9, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Trex Bio IPO price?
$14.00 a share.
When did Trex Bio go public?
Trex Bio listed on Nasdaq on Oct 9, 2026 under the ticker TRXB.
How much did the Trex Bio IPO raise?
$116.67M, before any underwriters' option.
How did Trex Bio open on its first day?
TRXB first traded at $13.50, -3.57% from the IPO price of $14.00.
How did TRXB close on its first day?
Its last regular-session trade was $15.48, +10.57% from the IPO price of $14.00.
What was the TRXB first-day trading range?
$13.50 to $15.50 in the regular session.
How many TRXB shares traded on the first day?
1.2M shares in the regular session.
How many shares did Trex Bio sell in its IPO?
8.33M shares.
What exchange is TRXB listed on?
Trex Bio lists on Nasdaq under the ticker TRXB.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the TRXB data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/TRXB/range/5/minute |
| Market cap | /v3/reference/tickers/TRXB |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.